Skip to main content
Log in

Calcium and vitamin D metabolism in granulomatous diseases

  • Review
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

Overproduction of the active metabolite of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)2D) has been described in sarcoidosis and other granulomatous diseases. High circulating concentrations of 1,25(OH)2D lead to increased intestinal absorption of calcium, possibly to enhanced bone resorption, and may result in hypercalcaemia and/or hypercalciuria. Data obtained in vivo and in vitro demonstrated that the unregulated production of 1,25(OH)2D lies within the granulomatous tissue and is controlled by glucocorticoids. This abnormal production of 1,25(OH)2D seems to be a general phenomenon of granulomatous processes, which is not exceptional in sarcoidosis, but appears seldom in tuberculosis. These abnormalities, however, are not pathognomonic of granulomatous processes, since they have been described in other diseases such as lymphomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Harrel, G.T., Fisher, S. Blood chemical changes in Boeck's sarcoid with particular reference to protein, calcium and phosphatase values. J Clin Invest, 1939, 18, 687–693.

    Google Scholar 

  2. Anderson, J., Harper, C., Dent, C.E., Philpot, G.R. Effect of cortisone on calcium metabolism in sarcoidosis with hypercalcaemia. Possibly antagonistic actions of cortisone and vitamin D. Lancet, 1954, ii: 720–724.

    Google Scholar 

  3. Winnacker, J.L., Becker, K.L., Katz, S. Endocrine aspects of sarcoidosis. N Engl J Med, 1968, 278, 427–434.

    Google Scholar 

  4. Shai, F., Baker, R.K., Addrizzo, J.R., Wallach, S. Hypercalcemia in mycobacterial infection. J Clin Endocrinol Metab, 1972, 34, 251–256.

    Google Scholar 

  5. Braman, S.S., Goldman, A.L., Schwartz, M.I. Steroid responsive hypercalcemia in disseminated bone tuberculosis. Arch Intern Med, 1973, 132, 269–271.

    Google Scholar 

  6. Bradley, G.W., Sterling, G.M. Hypercalcemia and hypokalemia in tuberculosis. Thorax, 1978, 33, 64–467.

    Google Scholar 

  7. Ryzen, E., Singer, F.R. Hypercalcemia in leprosy. Arch Intern Med, 1985, 145, 1305–1306.

    Google Scholar 

  8. Hoffman, V.N., Korzeniowski, O.M. Leprosy, hypercalcaemia, and elevated serum calcitriol levels. Ann Intern Med, 1986, 105, 890–891.

    Google Scholar 

  9. Lee, J.C., Catanzaro, A., Parthemore, J.G., Roach, B., Deftos, L.J. Hypercalcaemia in disseminated coccidioidomycosis. N Engl J Med, 1977, 297, 431–433.

    Google Scholar 

  10. Walter, R.M., Lawrence, R.M. Total ionized serum calcium and parathyroid hormone levels in patients with disseminated coccidioidomycosis. Am J Med Sci, 1981, 281, 97–99.

    Google Scholar 

  11. Walker, J.V., Baran, D., Yakub, Y.N., Freeman, R.B., Histoplasmosis with hypercalcaemic renal failure, and papillary necrosis. Confusion with sarcoidosis. JAMA, 1977, 237, 1350–1352.

    Google Scholar 

  12. Murray, J.J., Heim, C.R. Hypercalcemia in disseminated histoplasmosis. Aggravation by vitamin D. Am J Med, 1985, 78, 881–884.

    Google Scholar 

  13. Kantarjian, H.M., Saad, M.F., Estey, E.M., Sellin, R.V., Samaan, N.A. Hypercalcemia and disseminated candidiasis. Am J Med, 1982, 74, 721–724.

    Google Scholar 

  14. Jurney, T.H. Hypercalcaemia in a patient with eosinophilic granuloma. Am J Med, 1984, 76, 527–528.

    Google Scholar 

  15. Hellikson, M.A., Havey, A.D., Zerwekh, J.E., Breslau, N.A., Gardner, D.W. Plasma-cell granuloma producing calcitriol and hypercalcaemia. Ann Intern Med, 1986, 105, 379–381.

    Google Scholar 

  16. Stoeckle, J.D., Hardy, H.L., Weber, A.L. Chronic beryllium disease. Am J Med, 1969, 46, 545–561.

    Google Scholar 

  17. Kozeny, G.A., Barbato, A.L., Bansal, V.K., Vertuno, L.L., Hano J.E. Hypercalcemia associated with silicone-induced granulomas. N Engl J Med, 1984, 311, 1103–1105.

    Google Scholar 

  18. Henneman, P.H., Dempsey, E.F., Carroll, E.L., Albright, F. The cause of hypercalciuria in sarcoid and its treatment with cortisone and sodium phytate. J Clin Invest, 1956, 35, 1229–1242.

    Google Scholar 

  19. Bell, N.H., Gill, J.R., Bartter, F.C. On the abnormal calcium absorption in sarcoidosis. Am J Med, 1964, 36, 500–513.

    Google Scholar 

  20. Papapoulos, S.E., Fraher, L.J., Sandler, L.M., Clemens, T.L., Lewin, I.G., O'Riordan, J.L.H. 1,25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet, 1979, ii, 627–630.

    Google Scholar 

  21. Bell, N.H., Stern, P.H., Pantzer, E., Sinha, T.K., De Luca, H.F. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest, 1979, 64, 218–225.

    Google Scholar 

  22. Fraser, D.R., Kodicek, E. Unique biosynthesis by kidney of a biologically active vitamin D metabolite. Nature, 1979, 228, 764–766.

    Google Scholar 

  23. Fuss, M., Bergans, A., Gillet, C., Karmali, R., Pepersack, T., Bagon, J., Mandart, G., Corvilain J, Calcium metabolism disturbances in sarcoidosis. Acta Clin Belg, 1987, 42, 421–430.

    Google Scholar 

  24. Nosal, A., Schleissner, L.A., Mishkin, F.S., Lieberman, J. Angiotensin-I-converting enzyme and gallium scan in non-invasive evaluation of sarcoidosis. Ann Intern Med, 1979, 90, 328–331.

    Google Scholar 

  25. Katz, P., Fauci, A.S., Yeager, H. Jr., Reen, B.M. Serum angiotensin-converting enzyme and lysosyme in granulomatous diseases of unknown cause. Ann Intern Med, 1981, 94, 359–361.

    Google Scholar 

  26. Fuss, M., Bergans, A., Steppe, C., Dupont, E., Brauman, H., Corvilain, J. Effect of renal transplantation on serum 1,25 dihydroxyvitamine D3. In: Vitamin D, Chemical, Biochemical and Clinical Endorinology of Calcium Metabolism. Eds.: Norman A.W., Schaefer, K., von Herrath, D., Grigoleit, H.G., Berlin, New York, Walter de Gruyter & Co, 1982, 561–563.

    Google Scholar 

  27. Dent, C.E. Cortisone test for hyperparathyroidism. Br Med J, 1956, 1, 230–234.

    Google Scholar 

  28. Taylor, R.L., Lynch, H.J. Seasonal influence of sunlight on the hypercalcemia of sarcoidosis. Am J Med, 1963, 34, 221–227.

    Google Scholar 

  29. Phillips, R.W., Kirkpatrick, D.P. Steroid therapy of hypercalcaemia and renal insufficiency in sarcoidosis. N Engl J Med, 1956, 254, 1216–1222.

    Google Scholar 

  30. Scholz, D.A. Effect of steroid therapy on hypercalcaemia and renal insufficiency in sarcoidosis. JAMA, 1964, 169, 682–687.

    Google Scholar 

  31. Romer, F.K. Renal manifestations and abnormal calcium metabolism in sarcoidosis. Q J Med, 1980, 195, 233–247.

    Google Scholar 

  32. Zerwekh, J.E., Pak, C.Y.C., Kaplan, R.A., MacGuire, J.L., Upchurch, K., Breslau, N., Johnson, R. jr. Pathogenetic role of 1 alpha, 25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy. J Clin Endocrinol Metab, 1980, 51, 381–386.

    Google Scholar 

  33. Sandler, L.M., Winearls, C.G., Fraher, L.J., Clemens, T.L., Smith, R., O'Riordan, J.L.H. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxyvitamin D3. Q J Med, 1984, 210, 165–180.

    Google Scholar 

  34. Insogna, K.L., Dreyer, B.E., Mitnick, M., Ellison, A.F., Broadus, A.E. Enhanced production rate of 1,25-dihydroxyvitamin D in sarcoidosis. J Clin Endocrinol Metab, 1988, 66, 72–75.

    Google Scholar 

  35. Zimmerman, J., Holick, M.F., Silver, J. Normocalcaemia in a hypoparathyroid patient with sarcoidosis: evidence for parathyroid hormone-independent synthesis of 1,25 dihydroxyvitamin D. Ann Intern Med, 1983, 98, 338.

    Google Scholar 

  36. Mitchell, Th., Stamp, T.C.B., Jenkins, M.V., Mawer, E.B., Berry, J.L. Hypercalcaemic sarcoidosis in hypoparathyroidism. Br Med J, 1983, 286, 764–765.

    Google Scholar 

  37. Maesaka, J.K., Batuman, V., Pablo, M.C., Shakamuri, S. Elevated 1,25-dihydroxyvitamin D levels. Occurrence with sarcoidosis with end-stage renal disease. Arch Intern Med, 1982, 142, 1206–1207.

    Google Scholar 

  38. Koide, Y., Kugal, N., Kimura, S., Fujita, T., Yamashita, N., Hiramoto, T., Sukegawa, J., Ogata, E., Yamashita, K. Increased 1,25-dihydroxycholecalciferol as a cause of abnormal calcium metabolism in sarcoidosis. J Clin Endocrinol Metab, 1981, 52, 494–498.

    Google Scholar 

  39. Barbour, G.L., Coburn, J.W., Slatopolsky, E., Norman, A.W., Horst, R.L. Hypercalcaemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D: N Engl J Med, 1981, 305, 440–443.

    Google Scholar 

  40. Korkor, A., Gray, R., Lemann, J. Jr. Further evidence for extrarenal synthesis of 1,25(OH)2 vitamin D in sarcoidosis. Kidney Int, 1985, 27, 119.

    Google Scholar 

  41. Mason, R.S., Frankel, T., Chan, Y-L., Lissner, D., Posen, S. Vitamin D conversion by sarcoid lymph node homogenate. Ann Intern Med, 1984, 100, 59–61.

    Google Scholar 

  42. Adams, J.S., Sharma, O.P., Gacad, M.A., Singer, F.R. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest, 1983, 72, 1856–1860.

    Google Scholar 

  43. Fraher, L.J., Sandler, L.M., Karmali, R., Barker, S., Flint, K.C., Hudspith, B.N., Johnson, N.M., O'Riordan, J.L.H. The control of production of 1,25-dihydroxyvitamine D3 in men: studies of vitamin D deficiency and sarcoidosis. In: Vitamin D. A Chemical, Biochemical and Clinical Update. Eds: Norman A.W., Schaefer, K., Grigoleit H.G., von Herrath D. Berlin, New York, Walter de Gruyter & Co, 1985, 1064–1073.

    Google Scholar 

  44. Adams, J.S., Singer, F.R., Gacad, M.A., Sharma, O.P., Hayes, M.J., Vouros, P., Holick, M.F. Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J Clin endocrinol Metab, 1985, 60, 960–966.

    Google Scholar 

  45. Adams, J.S., Gacad, M.A. Characterization of 1, alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages on patients with sarcoidosis. J Exp Med, 1985, 161, 755–765.

    Google Scholar 

  46. Reichel, H., Koeffler, H.P., Norman, A.W. Synthesis in vitro of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by interferon-gamma-stimulated normal human bone marrow and alveolar macrophages. J Biol Chem, 1987, 262, 10931–10935.

    Google Scholar 

  47. Rigby, W.F.C., Denome, S., Fanger, M.W. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. J Clin Invest, 1987, 1659–1664.

  48. Reiner, M., Sigurdsson, G., Nunziata, V., Malik, M.A., Poole, G.W., Joplin, G.F. Abnormal calcium metabolism in normocalcemic sarcoidosis. Br Med J, 1976, 2, 1473–1476.

    Google Scholar 

  49. Breslau, N.A., Zerwekh, J.E., Nicar, M.J., Pak, C.Y.C. Effects of short term glucocorticoid administration in primary hyperparathyroidism: comparison to sarcoidosis. J Clin Endocrinol Metab, 1982, 54, 824–830.

    Google Scholar 

  50. Jackson, W.P.V., Doncaster, C.D. A consideration of the hypercalcaemia in sarcoidosis, idiopathic hypercalciuria, and that produced by vitamin D. J Clin Endocrinol Metab, 1959, 19, 658–680.

    Google Scholar 

  51. Bell, N.H., Bartter, F.C. Studies of47Ca metabolism in sarcoidosis: evidence for increased sensitivity of bone to vitamin D. Acta Endocrinol, 1967, 54, 173–180.

    Google Scholar 

  52. Dwarakanathan, A., Ryan, W.G. Hypercalcaemia of sarcoidosis treated with cellulose sodium phosphate. Bone Mineral, 1987, 2, 333–336.

    Google Scholar 

  53. Fallon, M.D., Perry, H.M., Teitelbaum, S.L. Skeletal sarcoidosis with osteopenia. Metab Bone Dis Relat Res, 1981, 3, 171–174.

    Google Scholar 

  54. Alexandre, C., Chappard, D., Vergnon, J.M., Emonot, A., Riffat, J. L'os dans la sarcoidose. Rev Rhum Mal Osteoartic, 1987, 54, 159–162.

    Google Scholar 

  55. Dent, C.E., Flynn, F.V., Nabarro, J.D.N. Hypercalcaemia and impairement of renal function in generalized sarcoidosis. Br Med J, 1953, ii, 808–810.

    Google Scholar 

  56. Scholz, D.A., Keating, R.F. Renal insufficiency, renal calculi and nephrocalcinosis in sarcoidosis. Am J Med, 1956, 21, 75–84.

    Google Scholar 

  57. Goldstein, R.A., Israel, H.L., Becker, K.L., More, C.F. The infrequency of hypercalcalcaemia in sarcoidosis. Am J Med, 1971, 51, 21–30.

    Google Scholar 

  58. Adams, J.S., Gacad, M.A., Singer, F.R., Sharma, O.P. Production of 1,25-dihydroxyvitamin D3 by pulmonary alveolar macrophages from patients with sarcoidosis. Ann N Y Acad Sci, 1986, 465, 585–594.

    Google Scholar 

  59. Sharma, O.P., Lamon, J., Winsor, D. Hypercalcaemia and tuberculosis. JAMA, 1972, 222, 582.

    Google Scholar 

  60. Abbasi, A.A., Chemplavil, J.K., Farah, S., Muller, B.F., Arnstein, R. Hypercalcaemia in active pulmonary tuberculosis. Ann Intern Med, 1979, 90, 324–328.

    Google Scholar 

  61. Need, A.G., Philips, P.J., Chiu, F.T.S., Prisk, H.M. Hypercalcaemia associated with tuberculosis. Br Med J, 1980, 280, 831.

    Google Scholar 

  62. Kitrou, M.P., Phytou-Pallikari, A., Tzannes, S.E., Virvidakis, K., Mountokalakis, T.D., Serum calcium during chemotherapy for active pulmonary tuberculosis. Eur J Respir Dis, 1983, 64, 347–354.

    Google Scholar 

  63. Gnokos, P.J., London, R., Hendler, E.D. Hypercalcaemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease in active tuberculosis. N Engl J Med, 1984, 311, 1683–1685.

    Google Scholar 

  64. Bell, N.H., Shary, J., Shaw, S., Turnere, R.T. Hypercalcaemia associated with increased circulating 1,25 dihydroxyvitamin D in a patient with pulmonary tuberculosis. Calcif Tissue Int 1985, 37, 588–591.

    Google Scholar 

  65. Isaacs, R.D., Nicholson, G.I., Holdaway, I.M. Miliary tuberculosis with hypercalcaemia and raised vitamin D concentrations. Thorax, 1987, 42, 555–556.

    Google Scholar 

  66. Peces, R., Alvarez, J. Hypercalcaemia and elevated 1,25(OH)2D3 levels in a dialysis patient with disseminated tuberculosis. Nephron, 1987, 46, 377–379.

    Google Scholar 

  67. Felsenfeld, A.J., Drezner, M.K., Llach, F. Hypercalcaemia and elevated calcitriol in a maintenance dialysis patient with tuberculosis. Arch Intern Med, 1986, 146, 1941–1945.

    Google Scholar 

  68. Cadranel, J., Hance, A.J., Minneron, B., Paillard, F., Akoun, J.M., Garabedian, M. Vitamin D metabolism in tuberculosis. Production of 1,25(OH)2D3 by cells recovered by bronchoalveolar lavage and the role of this metabolite in calcium homeostasis. Am Rev Respir Dis, 1988, 138, 984–989.

    Google Scholar 

  69. Adams, J.S., Modlin, R.L., Diz, M.M., Barnes, P.F. Potentiation of the macrophage 25-hydroxyvitamin D-1-hydroxylation reaction by human tuberculous pleural effusion fluid. J Clin Endocrinol Metab, 1989, 69, 457–460.

    Google Scholar 

  70. Fuss, M., Karmali, R., Pepersack, T., Bergans, A., Dierckx, P., Prigogine, T., Bergmann, P., Corvilain, J. Are tuberculous patients at risk from hypercalcaemia. Q J Med, 1988, 259, 869–878.

    Google Scholar 

  71. Fuss, M., Verbeelen, D., Geurts, J., Simon, J., Bergans, A., De Backer, M., Six, R., Corvilain, J. The use of a test for the differential diagnosis of hypercalciuria. Eur Urol, 1978, 4, 324–329.

    Google Scholar 

  72. Davies, P.D.O., Brown, R.C., Woodhead, J.S. Serum concentrations of vitamin D metabolism. Clin Parmacol Ther, 1982, 32, 525–530.

    Google Scholar 

  73. Brodie, M.J., Boobis, A.R., Hillyard, C.J., Abeyasekera, G., Stevenson, J.C., MacIntyre, I., Park, B.K. Effect of rifampicin and isoniazid on vitamin D metabolism. Clin Parmacol Ther, 1982, 32, 525–530.

    Google Scholar 

  74. Brodie, M.J., Boobis, A.R., Hillyard, C.J., Abeyasekera, G., MacIntyre, I., Park, B.K. Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity. Clin Pharmacol Ther, 1981, 30, 363–367.

    Google Scholar 

  75. Singhellakis, P.N., Kitrou, M.P., Alevizaki, C.C., Gonis, A.L., Tzannes, S.E., Virvidakis, C.E., Mountokalakis, T.D., Ikkos, D.G. Intestinal calcium absorption in patients with active pulmonary tuberculosis. Acta Endocrinol, 1983, 261, 36–37.

    Google Scholar 

  76. Kaminsky, J., Davidson, D.L. Serum calcium in pulmonary tuberculosis. Am Rev Tubercul, 1931, 23, 422–428.

    Google Scholar 

  77. Sharma, S.C. Serum calcium in pulmonary tuberculosis. Postgrad Med J, 1981, 57, 694–696.

    Google Scholar 

  78. Epstein, S., Stern, P.H., Bell, N.H., Dowdeswell, I., Turner, R.T. Evidence for abnormal regulation of circulating 1 alpha, 25-dihydoxyvitamin D in patients with pulmonary tuberculosis and normal cal calcium metabolism. Calcif Tissue Int, 1984, 36, 541–544.

    Google Scholar 

  79. Gwinup, G., Randazzo, G., Elias, A. The influence of vitamin D intake on serum calcium in tuberculosis. Acta Endocrinol, 1981, 97, 114–117.

    Google Scholar 

  80. Ralston, S.H., Cowan, R.A., Robertson, A.G., Gardner, M.D., Boyle, I.A. Circulating vitamin D metabolites and hypercalcaemia of malignancy. Acta Endocrinol, 1984, 106, 556–563.

    Google Scholar 

  81. Breslau, N.A., McGuire, J.L., Zerwekh, J.E., Frenkel, E.P., Pak, C.Y.C. Hypercalcemia associated with increased serum 1,25 dihydroxyvitamin D in 3 patients with lymphoma. Ann Intern Med, 1984, 100, 1–4.

    Google Scholar 

  82. Rosenthal, N., Insonga, K.L., Godsall, J.W., Smaldone, L., Waldron, J.A., Stewart, A.F. Elevations in circulating 1,25-dihydroxyvitamin D in 3 patients with lymphoma-associated hypercalcaemia. J Clin Endocrinol Metab, 1985, 60, 29–33.

    Google Scholar 

  83. Zaloga, J.P., Eil, C., Medbery, C.A. Humoral hypercalcaemia in Hodgkin's disease: association with elevated 1,25 dihydroxycholecalciferol levels and subperiosteal bone resorption. Arch Intern Med, 1985, 145, 155–157.

    Google Scholar 

  84. Davies, M., Hayes, M.E., Mawer, E.B., Lumb, J.A. Abnormal vitamin D3 metabolism in Hodgkin's lymphoma. Lancet, 1985b, i, 1186–1188.

    Google Scholar 

  85. Lambrecht, L., Boelaert, J., Louwagie, A., Criel, A., Daneels, R., Bouillon, R. Hypercalcaemia in Hodgkin's disease. Acta Clin Belg, 1986, 41, 37–42.

    Google Scholar 

  86. Mercier, R.J., Thompson, J.M., Harman, J.S., Messerschmidt, J.L. Recurrent hypercalcaemia and elevated 1,25 dihydroxyvitamin D levels in Hodgkin's disease. Am J Med, 1988, 84, 165–168.

    Google Scholar 

  87. Mude, A.H., Van Den Bergh, H., Boshuys, P.G., Breetveld, F.C., Marcus, H.M., Pluym, P.M., Bijvoet, O.L.M., Papapoulos, S.E. Ectopic production of 1,25-dihydroxyvitamin D by B-cell lymphoma as a cause of hypercalcaemia. Cancer, 1987, 59, 1543–1546.

    Google Scholar 

  88. Fetchick, D., Bertolini, D., Sarin, P., Weintraub, S., Mundy, G., Dunn, J. Production of 1,25-dihydroxyvitamin D3 by human T-cells lymphotropic virus-I-transformed lymphocytes. J Clin Invest, 1986, 78, 592–596.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fuss, M., Pepersack, T., Gillet, C. et al. Calcium and vitamin D metabolism in granulomatous diseases. Clin Rheumatol 11, 28–36 (1992). https://doi.org/10.1007/BF02207080

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02207080

Key words

Navigation